Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)-Reference-Cited by-同舟云学术

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)

Published:2017-05 Issue:5 Volume:151 Page:971-981
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Glassberg Marilyn K.,Minkiewicz Julia,Toonkel Rebecca L.,Simonet Emmanuelle S.,Rubio Gustavo A.,DiFede Darcy,Shafazand Shirin,Khan Aisha,Pujol Marietsy V.,LaRussa Vincent F.,Lancaster Lisa H.,Rosen Glenn D.,Fishman Joel,Mageto Yolanda N.,Mendizabal Adam,Hare Joshua M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Resp Crit Care Med.183(6):788-824.

2. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project;Travis;Am J Resp Crit Care Med,2008

3. Usual interstitial pneumonia: histologic correlation with high-resolution CT;Nishimura;Radiology,1992

4. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients;Johkoh;Radiology,1999

5. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19;Regenerative Therapy;2024-12

2. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

3. Idiopathic Pulmonary Fibrosis: Review of Current Knowledge;Physiological Research;2024-08-31

4. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

5. Exploring the effects of Saorilao-4 on the gut microbiota of pulmonary fibrosis model rats based on 16S rRNA sequencing;Journal of Applied Microbiology;2024-07